BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US
XTalks
JUNE 1, 2022
Osteomyelitis is a bone infection caused by fungi or bacteria. BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution. BONESUPPORT is an orthobiologics company focused on the management of bone injuries.
98 
Let's personalize your content